rs1333049 — CDKN2B-AS1 9p21 locus

ANRIL and the 9p21 Aging Accelerator — Senescence at the Heart of Cardiovascular Risk

A single region on chromosome 9 — the 9p21.3 locus — carries the most robustly replicated genetic association with coronary artery disease ever discovered. The rs1333049 variant sits within CDKN2B-AS1, the gene encoding ANRIL¹¹ ANRIL
Antisense Non-coding RNA in the INK4 Locus — a long non-coding RNA of 3,834 bp spanning 126 kb of the genome, positioned directly adjacent to the cell-cycle-inhibitor genes CDKN2A (p16-INK4a, p14-ARF) and CDKN2B (p15-INK4b). This cluster is not merely a cardiovascular locus — it is the master switch for cellular senescence in vascular tissue.

The C allele at rs1333049 is present in roughly 47% of people of European, South Asian, and East Asian descent, but only 26% of those of African ancestry. This extraordinary prevalence makes 9p21 among the most impactful polygenic cardiovascular risk factors in the human genome.

The Mechanism

ANRIL maintains the proliferative, non-senescent state of vascular smooth muscle cells and macrophages by recruiting Polycomb repressive complexes PRC1 and PRC2 to the CDKN2A/B loci (PRC2 deposits H3K27me3 marks that silence p16 and p15; PRC1 locks in this silencing), epigenetically suppressing p16-INK4a and p15-INK4b. When these suppressors are lifted — as happens in aging and atherosclerosis — cells exit the cell cycle and enter senescence, losing proliferative repair capacity and secreting pro-inflammatory factors that promote plaque vulnerability.

The risk C allele at rs1333049 alters ANRIL expression and splicing. The 9p21 risk haplotype disrupts enhancer elements within ANRIL's regulatory architecture, impairing the ANRIL–polycomb axis and allowing inappropriate early de-repression of p16 and p15 in vascular tissue. The consequence is accelerated vascular smooth muscle cell senescence and impaired repair capacity²² accelerated vascular smooth muscle cell senescence and impaired repair capacity
Studies in VSMCs from C-allele homozygotes showed lowest p16 and p15 expression alongside highest plaque burden, facilitating atherosclerotic plaque formation. Paradoxically, risk allele carriers show both dysregulated senescence induction and increased vascular inflammation — operating through a secondary interferon-γ pathway³³ secondary interferon-γ pathway
Harismendy et al. 2011 Nature showed 9p21 risk SNPs impair STAT1 binding at an IFN-γ-responsive enhancer.

The C allele is also associated with earlier coronary disease onset and higher cholesterol and triglyceride levels⁴⁴ earlier coronary disease onset and higher cholesterol and triglyceride levels
CC carriers develop coronary disease 2–5 years earlier; C allele increases total cholesterol, LDL-C, and triglycerides independently of lifestyle, effects that are independent of traditional cardiovascular risk factors.

The Evidence

The Samani et al. GWAS (NEJM 2007)⁵⁵ Samani et al. GWAS (NEJM 2007)
Joint analysis of the Wellcome Trust Case Control Consortium and German MI Family Study — 2,801 cases and 4,582 controls across two cohorts (WTCCC + German replication) reported rs1333049 as the top hit for CAD genome-wide (combined p = 2.91×10⁻¹⁹), with risk increased by 36% per copy of the C allele (OR 1.36 per allele; OR ~1.90 for CC vs GG). This has been replicated in dozens of populations across four continents.

A 2011 INTERHEART and FINRISK analysis⁶⁶ 2011 INTERHEART and FINRISK analysis
8,114 INTERHEART participants from 52 countries plus 19,129 FINRISK participants found that the 9p21 effect on MI risk was present only in individuals consuming low-prudent diets (OR 1.32, p < 0.001), was attenuated at medium intake (OR 1.17), and was statistically eliminated in individuals consuming the highest amounts of raw vegetables, fruits, and berries (OR 1.02, p = 0.68) (measured at LD proxy rs2383206). This is one of the most striking gene-diet interactions documented for a common cardiovascular variant.

Conversely, a study in a Hispanic cohort (n = 3,311)⁷⁷ a study in a Hispanic cohort (n = 3,311)
1,560 MI cases and 1,751 controls from Costa Rica found that high sugar-sweetened beverage intake exacerbated the 9p21 risk for myocardial infarction (measured at LD proxy rs4977574).

The locus also predicts disease severity: in the GRACE Genetics Study⁸⁸ GRACE Genetics Study
3,247 ACS patients followed prospectively, C allele carriers had HR 1.48 for recurrent MI and cardiac death within 6 months of an acute coronary syndrome.

From the longevity angle, a study of Spanish centenarians⁹⁹ study of Spanish centenarians
225 centenarians vs. 293 CAD-free healthy controls and 148 CAD controls found a non-significant trend (p=0.088) toward lower C-allele frequency in Spanish centenarians; this was not replicated in a Japanese cohort.

Practical Implications

The most actionable finding for C-allele carriers is the strong diet interaction. In the INTERHEART study, high raw vegetable and fruit intake dose-dependently attenuated and ultimately eliminated the genetic MI risk — suggesting specific food choices, not merely broad lifestyle patterns, interact with the 9p21 locus biology. The operative component is not vague "healthy eating" but specifically high load of raw, unprocessed plant foods¹⁰¹⁰ high load of raw, unprocessed plant foods
Raw vegetables preserve heat-labile phytonutrients that may directly counter the ANRIL-mediated inflammatory pathway. Eliminating sugar-sweetened beverages is separately supported as an action to avoid amplifying genetic risk.

For CC homozygotes in particular, measuring fasting insulin levels¹¹¹¹ measuring fasting insulin levels
The Swedish Obese Subjects study showed rs1333049 CC/CG carriers with elevated fasting insulin derived MI-preventing benefit from bariatric surgery (HR 0.72) may guide treatment decisions. Carriers with elevated fasting insulin may benefit especially from interventions that reduce hyperinsulinemia, including dietary carbohydrate restriction or, in severe obesity, bariatric surgery.

Given that 9p21 accelerates plaque formation rather than disease progression once plaque exists, coronary artery calcium (CAC) scoring is a rational targeted screening tool for C-allele carriers to detect subclinical atherosclerosis years before symptoms develop.

Interactions

rs1333049 is in near-perfect linkage disequilibrium with rs10757278 (r² = 1.0 in CEU) and high LD with rs4977574 (r² ≈ 0.89)¹²¹² near-perfect linkage disequilibrium with rs10757278 (r² = 1.0 in CEU) and high LD with rs4977574 (r² ≈ 0.89)
These SNPs are inherited together as a haplotype block and measure the same biological effect. Testing any one of these SNPs captures essentially the same 9p21 risk signal.

The 9p21 locus shows documented interaction with shorter telomere length on coronary artery disease prognosis: among CAD patients, those combining rs1333049 C allele with short telomeres have the worst cardiovascular outcomes¹³¹³ among CAD patients, those combining rs1333049 C allele with short telomeres have the worst cardiovascular outcomes
An additive interaction between 9p21 genotype and telomere length was found for CAD prognosis beyond either factor alone. Telomere length (rs12696304 in TERC) therefore compounds with 9p21 for longevity risk, though compound action advice requires both results.

The 9p21 locus additionally interacts with insulin metabolism: fasting insulin levels modify who benefits from weight-loss intervention, and dietary prudence modifies the genetic risk itself. This bidirectional nutrient-gene-metabolic interaction makes this locus unusually amenable to targeted dietary management.